This inventor holds 1 USPTO granted patent. Top assignee: Colorado State University Research Foundation. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Innovations by Kyle Garrett Ordway
Introduction
Kyle Garrett Ordway is an accomplished inventor based in Arvada, Colorado. He has made significant contributions to the field of medical devices, particularly in the area of cardiac health. His innovative approach to addressing mitral valve regurgitation showcases his dedication to improving patient outcomes.
Latest Patents
Kyle holds a patent for the "Remediation of functional cardiac mitral valve regurgitation." This dynamic device is designed to reduce functional mitral regurgitation by acting as a splint for the heart. It is positioned externally to the heart, which allows it to effectively prevent further dilation in patients diagnosed with cardiomyopathy. The device is attached to the outside of the left ventricle, eliminating the need for cardiopulmonary bypass during installation. This design significantly reduces surgical risks and minimizes exposure to the patient's blood, thereby lowering the risk of thromboembolic disease. Kyle has 1 patent to his name.
Career Highlights
Kyle is affiliated with the Colorado State University Research Foundation, where he continues to work on innovative solutions in medical technology. His research and development efforts are focused on creating devices that enhance the quality of life for patients with heart conditions.
Collaborations
Kyle collaborates with talented individuals in his field, including Eric Monnet and E Christopher Orton. Their combined expertise contributes to the advancement of medical device technology.
Conclusion
Kyle Garrett Ordway's work in developing a dynamic device for cardiac health exemplifies the impact of innovation in medicine. His contributions are paving the way for safer and more effective treatments for patients with mitral valve regurgitation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile